Enterprises breaches make more headlines, while smaller incidents tend to be under-reported, if at all, allowing such ...

Sakshi Agarwal: Theeyor Koodam was a self-discovery for me ...

One Belgian company is turning smartcards into powerful Bitcoin hardware wallets. With new funding and a U.S. expansion plan, Satochip is positioning itself at the heart of the self-custody revolution ...

Fresh-baked pastries and unforgettable blueberry pie draw travelers in. This cozy Maine bakery is a must-stop, even for ...

War movies are almost always films that have the good guys fighting evil forces, but there are some great war movies from a ...

Overview Java backend roles in 2026 demand strong fundamentals plus expertise in modern frameworks like Spring Boot and ...

The FDA has approved the first generic versions of Farxiga, a drug used to treat Type 2 diabetes and reduce the risk of hospitalization for heart failure. The generic, dapagliflozin, is indicated to ...

Novo Nordisk is facing a massive wave of generic competitors to its injectable formulations of GLP-1 agonist semaglutide, used to treat diabetes and obesity, as a key patent in India is due to expire ...

Generative artificial intelligence (GenAI) is opening the door for more researchers to conduct consumer studies than ever ...

March 31 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has again cut the prices of its blockbuster diabetes and weight-loss drugs Ozempic and Wegovy by up to 36% and 48% in India, to fend off ...

Generic dapagliflozin is indicated for adults with type 2 diabetes and to reduce heart failure hospitalization risk in adults with T2D and established cardiovascular disease. The Food and Drug ...

Generic dapagliflozin is indicated to lower heart failure hospitalization risk in type 2 diabetes with established cardiovascular disease or multiple risk factors, and to improve glycemic control ...